Triesence Injection, Suspension
Product Images NDC 0078-0897

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triesence (NDC 0078-0897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton.jpg (Carton)

Packaging label for Triesence (triamcinolone acetonide) injectable suspension ophthalmic injection by Novartis Pharmaceuticals. The label shows 40 mg/mL strength in a 1 mL single-use vial. It highlights that the product is preservative free and sterile. Storage instructions and manufacturer information are also included.*

FDA Label Image

Chemical (Chemical)

Chemical structure of triamcinolone acetonide, the active ingredient in TRIESENCE ophthalmic injection suspension 40 mg/mL by Novartis Pharmaceuticals Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.